Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
Open Access
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (2), 525-536
- https://doi.org/10.1016/j.ajpath.2010.10.002
Abstract
No abstract availableKeywords
Funding Information
- Marie Curie Canceromics (MEXT-CT-2003-2728)
- EU-PRIMA project (LSHC-CT-204-504587)
- TIME collaborative project
- Academy of Finland
- Cancer Organizations of Finland
- Sigrid Juselius Foundation
This publication has 55 references indexed in Scilit:
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15‐lipoxygenase‐2 in prostate cancerInternational Journal of Cancer, 2009
- Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterolMolecular and Cellular Endocrinology, 2008
- A yeast PAF acetylhydrolase ortholog suppresses oxidative deathFree Radical Biology & Medicine, 2008
- 15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3β and a Tumor Suppressor in Lung CancerCancer Research, 2008
- Expression and function of fatty acid amide hydrolase in prostate cancerInternational Journal of Cancer, 2008
- The evolving biology and treatment of prostate cancerJCI Insight, 2007
- What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?International Journal of Cancer, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006